Bill Nygren - Oakmark Funds
Holding/activity history for Charles River Laboratories International, Inc. (CRL)
← All CRL superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,153,296 | 0.50 | Add 28.36% | 0.11 | $146.33–228.88 · VW $183.88i | $371,443,560 | SEC |
| 2025 Q4 | 1,677,606 | 0.42 | Add 13.88% | 0.05 | $156.06–205.00 · VW $179.56i | $334,648,845 | SEC |
| 2025 Q3 | 1,473,084 | 0.37 | Add 26.67% | 0.08 | $144.26–184.17 · VW $160.51i | $230,478,723 | SEC |
| 2025 Q2 | 1,162,935 | 0.29 | Buy | 0.29 | $91.86–154.43 · VW $128.45i | $176,452,128 | SEC |
Price snapshot:
Current price$229.75
Avg. buy price$161.53
+/- since buy42.23%
52-week low$144.26
52-week high$237.86